Abstract:Xeroderma pigmentosum group C (XPC) is a versatile protein, crucial for sensing DNA damage in the global genome nucleotide excision repair (GG-NER) pathway. This pathway is vital for mammalian cells, acting as their essential approach for repairing DNA lesions stemming from interactions with environmental factors, such as exposure to ultraviolet (UV) radiation from the sun. Loss-of-function mutations in the gene confer a photosensitive phenotype in XP-C patients with the accumulation of unrepaired UV induced DNA damage. This remarkable increase in DNA damage tends to elevate by 10,000-fold the risk of developing melanoma and non-melanoma skin cancers. To date, creating accurate and reproducible models to study human XP-C disease has been an important challenge. To tackle this, we used CRISPR-Cas9 technology in order to knockout gene in various human skin cells (keratinocytes, fibroblasts, and melanocytes). After validation of the knockout in these edited skin cells, we showed that they recapitulate the major phenotypes of XPC mutations: photosensitivity and the impairment of UV induced DNA damage repair. Moreover, these mutated cells demonstrated a reduced proliferative capacity compared to their respective wild-type controls. Finally, to better mimic the disease environment, we built a 3D reconstructed skin using these XPC knockout skin cells. This model exhibited an abnormal behavior, showing an extensive remodeling of its extracellular matrix compared to normal skin. Analyzing the composition of the fibroblasts secretome revealed a significant augmented shift in the inflammatory response following XPC knockout. Our innovative “disease on a dish” approach can provide valuable insights into the molecular mechanisms underlying XP-C disease, paving the way to design novel preventive and therapeutic strategies to alleviate the disease phenotype. Also, given the high risk of skin cancer onset in XP-C disease, our new approach can also serve as a link to draw novel insights towards this elusive field.

Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients

Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice

Xeroderma pigmentosum--bridging a gap between clinic and laboratory

Development of effective skin cancer treatment and prevention in xeroderma pigmentosum

Deep intronic founder mutations identified in the ERCC4/ XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum

Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum

Xeroderma Pigmentosum: General Aspects and Management

Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity

[Xeroderma pigmentosum: children of the moon]

Xeroderma Pigmentosum Type C Primary Skin Fibroblasts Overexpress HGF and Promote Squamous Cell Carcinoma Invasion in the Absence of Genotoxic Stress

Mutational signatures and increased retrotransposon insertions in xeroderma pigmentosum variant skin tumors

Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model

Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers

Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients

Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients

Photodynamic Therapy in the Treatment of Xeroderma Pigmentosum: A Case Report

Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child

Xeroderma Pigmentosum - Facts and Perspectives

Generation and characterization of CRISPR-Cas9-Mediated Gene Knockout in Human Skin Cells

Synthetic rescue of Xeroderma Pigmentosum C phenotype via PIK3C3 downregulation